What You Should Know About KBroVet®-CA1: The Once-Daily Option for Canine Epilepsy
Canine epilepsy is one of the most common neurologic disorders veterinarians encounter, yet managing it effectively can often be complex and frustrating—for both practitioners and pet owners. From inconsistent dosing to limited pharmaceutical options developed specifically for dogs, long-term seizure control has traditionally presented significant challenges.
Now, with of KBroVet®-CA1 by PRN Pharmacal, veterinarians have a new, promising solution. This is the first FDA-conditionally approved potassium bromide medication designed specifically for dogs with idiopathic epilepsy—and it brings with it a host of advantages for both clinicians and clients.
Veterinary neurologist Dr. Philip Cohen, based in Connecticut, views KBroVet®-CA1 as a meaningful advancement in the medical management of seizures. “Consistency is key when it comes to seizure control,” says Dr. Cohen. “Having a medication that is not only reliable but also designed with dogs in mind makes a big difference in how we manage these cases.”
What Makes KBroVet®-CA1 Different?
Veterinary-Exclusive Formulation
Unlike compounded alternatives, KBroVet®-CA1 is manufactured specifically for canine use and flavored for palatability—helping to improve acceptance and adherence.
Once-Daily Dosing
The medication’s once-a-day dosing schedule improves owner compliance and simplifies treatment routines, a critical factor in achieving long-term seizure control.
FDA-Conditionally Approved
Approved under the FDA’s Minor Use/Minor Species (MUMS) program, KBroVet®-CA1 provides veterinarians with a trusted and regulated option that fills a long-standing gap in epilepsy care for dogs.
Adjunct Therapy Compatibility
KBroVet®-CA1 can be safely and effectively used alongside other anticonvulsant medications, such as phenobarbital, allowing for flexible treatment plans.
Not a Scheduled Drug
As a non-scheduled medication, it is easier for veterinarians to prescribe and for clients to access—further reducing barriers to consistent care.
Supporting Pets and Their People
KBroVet®-CA1 offers a much-needed, dependable tool for seizure management—helping improve quality of life not only for dogs affected by epilepsy but also for the families who care for them. With its targeted formulation and simplified dosing, it addresses the practical challenges of epilepsy treatment head-on.
For veterinarians seeking to elevate their neurology protocols, KBroVet®-CA1 is a welcome addition to the pharmaceutical toolbox.
Get prescribing information here:
